Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anaphylaxis.

M Fisher

    Disease-A-Month : DM
    |August 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Anaphylactic shock involves diverse mechanisms and mediators like histamine. Prompt treatment with epinephrine and supportive care, alongside identifying triggers, is crucial for patient safety and preventing future reactions.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Simultaneous presentation of Goodpasture's disease and insulin-dependent diabetes mellitus.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1999
    Same author

    ICU admission in patients infected with the human immunodeficiency virus - a multicentre survey.

    Anaesthesia·1999
    Same author

    Novel cationic amphiphiles as delivery agents for antisense oligonucleotides.

    Nucleic acids research·1999
    Same author

    Interventional cardiology in people with diabetes.

    Diabetic medicine : a journal of the British Diabetic Association·1999
    Same author

    Neuroprotective effects of a novel broad-spectrum cation channel blocker, LOE 908 MS, on experimental focal ischemia: a multispectral study.

    Journal of magnetic resonance imaging : JMRI·1999
    Same author

    Transforming growth factor-beta mediates astrocyte-specific regulation of brain endothelial anticoagulant factors.

    Stroke·1999
    Same journal

    Disturbances due to cold.

    Disease-a-month : DM·2026
    Same journal

    GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

    Disease-a-month : DM·2026
    Same journal

    GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

    Disease-a-month : DM·2026
    Same journal

    Periodontal disease and diabetic kidney disease: A comprehensive analysis.

    Disease-a-month : DM·2026
    Same journal

    Foreword for Glucagon-like peptide-1 receptor agonists (GLP-1) and its promise for potential benefits.

    Disease-a-month : DM·2026
    Same journal

    Foreword for insulin autoimmune syndrome (Hirata Disease): An updated review of epidemiology, pathophysiology, clinical features, diagnosis, and management.

    Disease-a-month : DM·2026
    See all related articles

    Area of Science:

    • Immunology
    • Pharmacology
    • Clinical Medicine

    Background:

    • Anaphylactic shock is a complex clinical syndrome.
    • It arises from immunologic and non-immunologic mechanisms.
    • Mediator release, primarily histamine, drives the reaction.

    Purpose of the Study:

    • To outline the mechanisms and contributing factors of anaphylactic shock.
    • To detail the primary treatment strategies.
    • To emphasize the importance of follow-up and trigger identification.

    Main Methods:

    • Review of clinical syndrome mechanisms.
    • Discussion of pharmacological and environmental factors.
    • Emphasis on clinical history and diagnostic approaches.

    Main Results:

    • Anaphylactic shock results from mediator release.
    • Epinephrine, volume replacement, and ventilation are primary treatments.
    • Patient history is often more valuable than diagnostic tests.

    Conclusions:

    • Anaphylactic shock is multifactorial, with unpredictable onset.
    • Effective management includes immediate treatment and thorough investigation.
    • Preventive measures like H1/H2 blockers may benefit high-risk patients.